'Price-Gouging' Drug CEO Not Happy With Bernie Sanders
Presidential candidate rejected Martin Shkreli's donation
By Evann Gastaldo,  Newser Staff
Posted Oct 19, 2015 4:25 PM CDT
Carrying an image of Turing Pharmaceuticals CEO Martin Shkreli, activists are asked to leave a New York lobby on Oct. 1, 2015, during a protest highlighting pharmaceutical drug pricing.   (AP Photo/Craig Ruttle)

(Newser) – Martin Shkreli, possibly America's most-hated drug CEO, is "SO ANGRY AT @BernieSanders I COULD PUNCH A WALL!!!!!!!!!!!!!!!!!!!!!!!1." That's what Shkreli, CEO of Turing Pharmaceuticals, tweeted Sunday night after Bernie Sanders rejected a $2,700 donation from Shkreli. Though Shkreli may have been kidding about that (related tweets from himself and others referenced him "trolling" his followers), he followed that up with a few tweets about how Sanders raised the donation amount he asked for from supporters in a recent Shkreli-related fundraising email from $3 to $25.66, or, as Shkreli put it, "raised the donation requested from his supporters by 755% in one day. Price gouging."

Shkreli, who famously "price gouged" the drug Daraprim about 5,000%, from $13.50 to $750, also told CNN Money Sunday that he donated to Sanders "in hopes of meeting him and discussing" pharmaceutical policy. "I find it bizarre that he won't engage me because he's been willing to use my name," Shkreli said. "He singled me out, but dozens of drug companies have done what I've done."